89Zr-trastuzumab

⁸⁹Zr-trastuzumab is a molecular imaging agent used for positron emission tomography (PET) imaging. It consists of the monoclonal antibody trastuzumab, which specifically targets the human epidermal growth factor receptor 2 (HER2), labeled with the radioisotope zirconium-89 (89Zr).This radiopharmaceutical facilitates non-invasive imaging of HER2-positive tumors, aiding in the assessment of the extent and distribution of HER2 expression in various cancers. This imaging can be crucial for treatment planning, monitoring response to therapy, and disease staging, particularly in breast cancer.

Virtual price, please inquire if needed.We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.

msds of 89 zirconium-trastuzumab